Q3714_canaural_ear_dro.1_8.tp

Dechra Veterinary Products
Limited
(A business unit of Dechra
Pharmaceuticals PLC)
Sansaw Business Park
Hadnall, Shrewsbury
Shropshire SY4 4AS
Tel: 01939 211200
CANAURAL® EAR DROPS, SUSPENSION FOR
treatment period is prolonged, in vitro sensitivity DOGS AND CATS
Advice on correct administration: Official, national Presentation
and regional antimicrobial policies should be taken into account when the product is used.
Contra-indications, warnings, etc
Do not use concomitantly with products known to Do not use in animals with known hypersensitivity Canaural® is effective against the micro-or- to the active substances or to the excipient.
ganisms commonly associated with otitis externa, Not recommended for use in pregnant animals.
including the ear mite, Otodectes cynotis, and is Adverse reactions: Allergy or hypersensitivity reac- specifically formulated for the treatment of otitis tions to the active substances or the excipient might Anti-inflammatory corticosteroids such as predni- administration Where
solone are known to exert a wide range of side prior to administration, the ear canal and the sur- effects. Dosage in medium to long term use should rounding area should be cleaned mechanically or by therefore generally be kept to the minimum.
irrigation, taking care to avoid further damage to the During therapy, effective doses suppress the hy- skin. Any excess exudate, hair or debris should be pothalamo-pituitreal-adrenal axis. Following cessa- carefully removed prior to the application of the ear tion of treatment symptoms of adrenal insufficiency drops. Animal owners should only do this on the can arise and this may render the animal unable to direction of the prescribing veterinary surgeon.
deal adequately with stressful situations.
Corticosteroids may delay wound healing and the Instil 5-10 drops into the ear according to the size of immunosuppressant actions may weaken resistance the animal and ear canal twice daily. Without allowing to, or exacerbate existing infections.
the animal to shake its head, very gently massage the If you notice any serious effects or other effects not ear canal after administration holding the pinna in an mentioned in the data sheet, please inform your upright position to ensure penetration of the drops Special precautions for use in animals: Following Where ear mite infection is present, consideration recovery the ears should be checked at regular should be given to treating both ears, even if infection intervals for any signs of re-infection.
is apparent in only one. Treatment should continue Special precautions to be taken by the person for at least 3 weeks to ensure that successive genera- administering the veterinary medicinal product to tions of ear mites are killed. Animals that are in animals: Avoid skin contact with this product. Wash hands thoroughly after applying the product.
Where treatment is for a period longer than 7 days, In case of accidental eye contact, rinse thoroughly regular clinical re-evaluation should be carried out.
Where Gram-negative infections are involved, the use People with known hypersensitivity to any of the of the veterinary medicinal product should be based active substances or the excipient should avoid on bacterial sensitivity testing. In cases where the contact with the veterinary medicinal product.
Special warnings: For animal treatment only.
For external use only.
To be used under veterinary supervision.
Further information
Not recommended for use in pregnant and lactating the batch release: Dales Pharmaceuticals, Snaygill Industrial Estate, Keighley Road, Skipton, North York- Pharmaceutical precautions
25˚C. Protect from direct sunlight. Keep the bottle in To be supplied only on veterinary prescription.
the outer carton. Keep out of the reach and sight of Veterinary medicinal product authorised for use in Do not use after the expiry date stated on the label Shelf life after first opening the container: 3 months.
Marketing authorisation holder (if different from
In order to calculate the date on which any product distributor)
remaining in the bottle should be discarded, add 3 months to the date on which the bottle is opened forthe first time. This discard date should be written in Marketing authorisation number Vm 24883/4004
Disposal: Dispose of any unused product and empty containers in accordance with guidance from GTIN (Global Trade Item No)
your local waste regulation authority.
Canaural Ear Drops, Suspension for Dogs and Cats15 ml 05055031500048 Legal category POM-V
Canaural Ear Drops, Suspension for Dogs and Cats Packaging quantities
tles, supplied in boxes of 1 × 15 ml, 10 x 15 ml, 1 × Canaural Ear Drops, Suspension for Dogs and Cats Requested by: kate.gittins@dechra.com
Approved datasheets found: 1
Creation date: 2/3/2011 13:42:49 (UK)
Approved for book but not on website: 0
Datasheets marked as draft (ignored): 0
Canaural Ear Drops, Suspension for Dogs and Directory of participants
Dechra Veterinary Products
Limited
(A business unit of Dechra
Pharmaceuticals PLC)
Sansaw Business Park
Hadnall, Shrewsbury
Shropshire SY4 4AS
Tel: 01939 211200Fax: 01939 211201email: info@dechra-uk.comwww.dechra.com LIST OF PRODUCTS BY THERAPEUTIC INDICATION List of Products by Therapeutic Indication
PHARMACEUTICALS
Antimicrobials
Topical preparations
List of Products by Species
Please note that a species in brackets after a product name may not necessarily be a part of that product namebut is intended to make the index easier to use.
Canaural Ear Drops, Suspension for Dogs and Canaural Ear Drops, Suspension for Dogs and List of Products by Active Ingredients
This index of non-proprietary names (active ingredients) is provided to enable users of the Compendium toidentify the brand names of relevant products when only the non-proprietary names are known.
It should be noted that although different products may contain the same active ingredient this does not implythat they are equivalent in regard to bioavailability or therapeutic activity.
Some products contain a number of ingredients and it has not been possible in every instance to identify suchproducts by a reference in this index to each ingredient.
Non-proprietary name in bold type. Proprietary name in ordinary type.
Diethanolamine Fusidate
Nystatin
Canaural Ear Drops, Suspension for Dogs and Canaural Ear Drops, Suspension for Dogs and Framycetin Sulfate
Prednisolone
Canaural Ear Drops, Suspension for Dogs and Canaural Ear Drops, Suspension for Dogs and GRED
IN
E
IV

Alphabetical Index of Products

Source: http://dechra.dk/files/dechra/Downloads/Pharma/Datasheets/Canaural_Ear_Drops_Suspension_for_Dogs_and_Cats-02-03-11pdf.pdf

Untitled

This free weekly bulletin lists the latest research on cerebral palsy (CP), as indexed in the NCBI, PubMed (Medline) and Entrez (GenBank) databases. These articles were identified by a search using the key term "cerebral palsy". To subscribe, please email Robyn Cummins rcummins@cerebralpalsy.org.au with ‘Subscribe to CP Research News’ in the subject line, and your name and email addr

Microsoft word - cv

4808-2600 int. 2177, 2106 SALGUERO 2835 1° (1425) CABA 4806-1296 ACTIVIDAD PROFESIONAL: (últimos cinco años) MEDICO DE PLANTA DEL SERVICIO DE PEDIATRIA DE CONSULTORIOS EXTERNOS EN EL HOSPITAL GENERAL DE AGUDOS JUAN A. FERNANDEZ. CONTINUA EN LA ACTUALIDAD. Ingreso en la Municipalidad EL 01/0171988 becario Municipal en la especialidad de Neonatologia. El 10/01/1989 Especialista en la guard

© 2010-2017 Pharmacy Pills Pdf